BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 25116427)

  • 1. Safety and efficacy of warfarin plus aspirin combination therapy for giant coronary artery aneurysm secondary to Kawasaki disease: a meta-analysis.
    Su D; Wang K; Qin S; Pang Y
    Cardiology; 2014; 129(1):55-64. PubMed ID: 25116427
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comment on the paper by Su et al. entitled 'safety and efficacy of warfarin plus aspirin combination therapy for giant coronary artery aneurysm secondary to kawasaki disease: a meta-analysis'.
    Loomba RS
    Cardiology; 2015; 130(3):164-5. PubMed ID: 25676566
    [No Abstract]   [Full Text] [Related]  

  • 3. Warfarin plus aspirin or aspirin alone for patients with giant coronary artery aneurysms secondary to Kawasaki disease?
    Levin M; Burns JC; Gordon JB
    Cardiology; 2014; 129(3):174-7. PubMed ID: 25300244
    [No Abstract]   [Full Text] [Related]  

  • 4. Multicenter and retrospective case study of warfarin and aspirin combination therapy in patients with giant coronary aneurysms caused by Kawasaki disease.
    Suda K; Kudo Y; Higaki T; Nomura Y; Miura M; Matsumura M; Ayusawa M; Ogawa S; Matsuishi T
    Circ J; 2009 Jul; 73(7):1319-23. PubMed ID: 19436123
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Prevention of thrombosis of coronary aneurysms in patients with a history of Kawasaki disease].
    Suda K; Kudo Y; Sugawara Y; Ishii M; Matsuishi T
    Nihon Rinsho; 2008 Feb; 66(2):355-9. PubMed ID: 18265459
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of initial corticosteroid therapy on coronary artery aneurysm formation in Kawasaki disease: a meta-analysis of 862 children.
    Wooditch AC; Aronoff SC
    Pediatrics; 2005 Oct; 116(4):989-95. PubMed ID: 16199713
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adjusted indirect meta-analysis of aspirin plus warfarin at international normalized ratios 2 to 3 versus aspirin plus clopidogrel after acute coronary syndromes.
    Testa L; Zoccai GB; Porto I; Trotta G; Agostoni P; Andreotti F; Crea F
    Am J Cardiol; 2007 Jun; 99(12):1637-42. PubMed ID: 17560866
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Thromboprophylaxis in patients with coronary aneurysms caused by Kawasaki disease].
    Suda K
    Nihon Rinsho; 2014 Sep; 72(9):1659-63. PubMed ID: 25518419
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combination antithrombotic therapy with antiplatelet agents and anticoagulants for patients with atherosclerotic heart disease.
    Arjomand H; Cohen M; Ezekowitz MD
    J Invasive Cardiol; 2004 May; 16(5):271-8. PubMed ID: 15152137
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Author's Reply.
    Su D; Wang K; Qin S; Pang Y
    Cardiology; 2015; 130(3):166. PubMed ID: 25676687
    [No Abstract]   [Full Text] [Related]  

  • 11. [Safety of warfarin therapy in children with coronary aneurysm due to Kawasaki disease].
    He XH; Zhu QL; Yuan YH; Long XD; Xia XH; Wang S; Hu C
    Zhonghua Er Ke Za Zhi; 2021 Feb; 59(2):95-100. PubMed ID: 33548954
    [No Abstract]   [Full Text] [Related]  

  • 12. Warfarin therapy for giant aneurysm prevents myocardial infarction in Kawasaki disease.
    Sugahara Y; Ishii M; Muta H; Iemura M; Matsuishi T; Kato H
    Pediatr Cardiol; 2008 Mar; 29(2):398-401. PubMed ID: 18027010
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The prevention of coronary artery aneurysm in Kawasaki disease: a meta-analysis on the efficacy of aspirin and immunoglobulin treatment.
    Durongpisitkul K; Gururaj VJ; Park JM; Martin CF
    Pediatrics; 1995 Dec; 96(6):1057-61. PubMed ID: 7491221
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Six Kawasaki disease patients with acute coronary artery thrombosis].
    Zhou SL; Luo JP; Qi YQ; Liang YG; Wang W; Gong FQ
    Zhonghua Er Ke Za Zhi; 2013 Dec; 51(12):925-9. PubMed ID: 24495764
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Coronary artery aneurysm in Kawasaki disease: from multimodality imaging.
    Lee CH; Kim U
    Coron Artery Dis; 2020 Mar; 31(2):193-194. PubMed ID: 31821196
    [No Abstract]   [Full Text] [Related]  

  • 16. [Kawasaki disease in children--9 years experience].
    Kowalczyk M; Kawalec W; Daszkowska-York J; Turska-Kmieć A; Brzezińska-Rajszys G; Sobielarska D; Ziółkowska L; Kościesza A; Jagiełłowicz D; Mirecka-Rola A
    Med Wieku Rozwoj; 2005; 9(2):179-93. PubMed ID: 16085959
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Warfarin versus aspirin for prevention of stroke in heart failure: a meta-analysis of randomized controlled clinical trials.
    Kumar G; Goyal MK
    J Stroke Cerebrovasc Dis; 2013 Nov; 22(8):1279-87. PubMed ID: 23182364
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety and efficacy of combined antiplatelet-warfarin therapy after coronary stenting.
    Karjalainen PP; Porela P; Ylitalo A; Vikman S; Nyman K; Vaittinen MA; Airaksinen TJ; Niemelä M; Vahlberg T; Airaksinen KE
    Eur Heart J; 2007 Mar; 28(6):726-32. PubMed ID: 17267456
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Improving the diagnosis and therapy of Kawasaki disease].
    Du JB
    Zhonghua Er Ke Za Zhi; 2006 May; 44(5):321-3. PubMed ID: 16780704
    [No Abstract]   [Full Text] [Related]  

  • 20. Pediatric Thromboprophylaxis of Large Coronary Artery Aneurysm Using Rivaroxaban.
    Montanez N; Sexson Tejtel SK; Menon NM
    J Pediatr Hematol Oncol; 2023 Aug; 45(6):356-359. PubMed ID: 37314881
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.